Matthew Dankner
Impact in
- Oncology top 10%
- Colorectal Cancer Treatments and Studies
- Cancer Immunotherapy and Biomarkers
- Cutaneous Melanoma Detection and Management
- Pathology and Forensic Medicine top 10%
- Cancer Mechanisms and Therapy
Papers in
-
- Brain Metastases and Treatment 7
- Lung Cancer Treatments and Mutations 7
- Oncology 14
- Colorectal Cancer Treatments and Studies 4
- Co-authors
- April A. N. Rose (14 shared papers)Peter M. Siegel (11 shared papers)Ian R. Watson (4 shared papers)Shivshankari Rajkumar (4 shared papers)Richard S. Blumberg (1 shared paper)Scott D. Gray‐Owen (1 shared paper)Nicole Beauchemin (1 shared paper)Yu‐Hwa Huang (1 shared paper)
- Journals
- JCO Precision Oncology (2 papers)Neuro-Oncology Advances (2 papers)Cancers (2 papers)Journal of Clinical Oncology (2 papers)Clinical and investigative medicine (2 papers)
- Partner nations
- CanadaUnited StatesSpain
In The Last Decade
Matthew Dankner
26 papers receiving 731 citations
Matthew Dankner's Hit Papers
Peers
Comparison fields: 5 of 73
- Oncology 374
- Pathology and Forensic Medicine 152
- Cancer Research 119
- Pulmonary and Respiratory Medicine 222
- Molecular Biology 390
Countries citing papers authored by Matthew Dankner
This map shows the geographic impact of Matthew Dankner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthew Dankner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthew Dankner more than expected).
Fields of papers citing papers by Matthew Dankner
This network shows the impact of papers produced by Matthew Dankner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthew Dankner. The network helps show where Matthew Dankner may publish in the future.
Co-authors
The 25 scholars most cited alongside Matthew Dankner, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 29 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Classifying BRAF alterations in cancer: new rational therapeutic strategies for actionable mutations Hit paper breakdown → | 2018 | 348 |
| 2 | 2017 | 94 | |
| 3 | Neoadjuvant Chemoimmunotherapy for NSCLC Hit paper breakdown → | 2024 | 89 |
| 4 | 2018 | 47 | |
| 5 | 2024 | 20 | |
| 6 | 2023 | 19 | |
| 7 | 2021 | 17 | |
| 8 | 2022 | 16 | |
| 9 | 2018 | 16 | |
| 10 | 2018 | 15 | |
| 11 | 2022 | 14 | |
| 12 | 2020 | 12 | |
| 13 | 2019 | 9 | |
| 14 | 2024 | 7 | |
| 15 | 2024 | 5 | |
| 16 | 2024 | 3 | |
| 17 | 2019 | 3 | |
| 18 | 2024 | 2 | |
| 19 | 2024 | 2 | |
| 20 | 2022 | 2 |
About Matthew Dankner
Matthew Dankner is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Molecular Biology, Pathology and Forensic Medicine and Genetics, having authored 29 papers that have together received 747 indexed citations. Recurring topics across this work include Melanoma and MAPK Pathways (9 papers), Brain Metastases and Treatment (7 papers), Lung Cancer Treatments and Mutations (7 papers), Cancer Mechanisms and Therapy (5 papers), Colorectal Cancer Treatments and Studies (4 papers), Glioma Diagnosis and Treatment (3 papers), Computational Drug Discovery Methods (2 papers) and Health and Medical Research Impacts (2 papers). The work is most often cited by research in Oncology (374 citations), Pathology and Forensic Medicine (152 citations), Cancer Research (119 citations), Pulmonary and Respiratory Medicine (222 citations) and Molecular Biology (390 citations). Matthew Dankner has collaborated with scholars based in Canada, United States and Spain. Frequent co-authors include April A. N. Rose, Peter M. Siegel, Ian R. Watson, Shivshankari Rajkumar, Richard S. Blumberg, Scott D. Gray‐Owen, Nicole Beauchemin, Yu‐Hwa Huang, Kevin Petrecca and Logan A. Walsh. Their work appears in journals such as JCO Precision Oncology, Neuro-Oncology Advances, Cancers, Journal of Clinical Oncology and Clinical and investigative medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.